Real-life studies in allergen immunotherapy

被引:12
|
作者
Passalacqua, Giovanni [1 ]
Bagnasco, Diego [1 ]
机构
[1] Univ Genoa, Allergy & Resp Dis, IRCCS Policlin San Martino, Lgo R Benzi 10, I-16133 Genoa, Italy
关键词
allergen immunotherapy; efficacy; real life; real world; safety; RANDOMIZED CONTROLLED-TRIALS; ADVERSE SYSTEMIC REACTIONS; SUBLINGUAL IMMUNOTHERAPY; EUROPEAN SURVEY; ASTHMA; RHINITIS; SAFETY; MANAGEMENT; EFFICACY; EASSI;
D O I
10.1097/ACI.0000000000000757
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review Real-life (or real-world) studies can provide information that cannot be derived from randomized controlled trials. This approach is currently becoming of relevance for many treatments. In recent years, the real-life method has been applied also to allergen immunotherapy, providing new insights on it. We reviewed herein the available literature on the argument. Recent findings Several prospective and retrospective studies on allergen immunotherapy in the real-world setting have been published, mostly in the last 5 years. Most of them focused on adverse events, compliance, and the long term/preventive effects, and evidenced an overall favorable profile for different products and different allergens. Real life study provided novel information and evidenced those aspects of immunotherapy that worth a more detailed approach, without the strict limitations usually imposed by controlled randomized trials.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 50 条
  • [41] Real-life experience with hazelnut oral immunotherapy
    Sabouraud, Marie
    Bierme, Priscille
    Andre-Gomez, Sylvie-Anne
    Villard-Truc, Florence
    Payot, Francois
    Correard, Anne-Karine
    Garnier, Lorna
    Braun, Camille
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 128 (04) : 432 - 438
  • [42] How can we improve our use of allergen immunotherapy as a treatment option for asthma and severe asthma?
    Larenas-Linnemann, Desiree
    Maciel, Blanca Maria Morfin
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (08) : 717 - 725
  • [43] Allergen immunotherapy: an updated review of safety
    James, Christine
    Bernstein, David I.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 17 (01) : 55 - 59
  • [44] Allergen Immunotherapy History and Future Developments
    Passalacqua, Giovanni
    Canonica, Giorgio Walter
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2016, 36 (01) : 1 - +
  • [45] Allergen immunotherapy in asthma; what is new?
    Passalacqua
    G.
    Rogkakou
    A.
    Mincarini
    M.
    Canonica
    G.W.
    Asthma Research and Practice, 1 (1)
  • [46] Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis
    Wang, Zhong-xi
    Shi, Han
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2017, 37 (03) : 407 - 411
  • [47] The contribution of sublingual immunotherapy to the achievement of control in birch-related mild persistent asthma: A real-life randomised trial
    Marogna, M.
    Braidi, C.
    Bruno, M. E.
    Colombo, C.
    Colombo, F.
    Massolo, A.
    Palumbo, L.
    Compalati, E.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2013, 41 (04) : 216 - 224
  • [48] 'Real-life' effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review
    Abraham, I.
    Alhossan, A.
    Lee, C. S.
    Kutbi, H.
    MacDonald, K.
    ALLERGY, 2016, 71 (05) : 593 - 610
  • [49] Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile
    Calderon, M. A.
    Simons, F. E. R.
    Malling, H. -J.
    Lockey, R. F.
    Moingeon, P.
    Demoly, P.
    ALLERGY, 2012, 67 (03) : 302 - 311
  • [50] Real-Life Clinical Experience With Cariprazine: A Systematic Review of Case Studies
    Csehi, Reka
    Dombi, Zsofia Borbala
    Sebe, Barbara
    Molnar, Maria Judit
    FRONTIERS IN PSYCHIATRY, 2022, 13